These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Evidence that the thymus has no significant role in donor-specific blood transfusion-induced rat renal allograft enhancement. Blow O; Baldwin WM; Sanfilippo FP Transplantation; 1993 Dec; 56(6):1558-60. PubMed ID: 8279040 [No Abstract] [Full Text] [Related]
43. Persistent infiltration of CD45RC- CD4+ T cells, Th2-like effector cells, in prolonging hepatic allografts in rats pretreated with a donor-specific blood transfusion. Miyanari N; Yamaguchi Y; Matsuno K; Tominaga A; Goto M; Ichiguchi O; Mori K; Ogawa M Hepatology; 1997 Apr; 25(4):1008-13. PubMed ID: 9096612 [TBL] [Abstract][Full Text] [Related]
44. Donor-specific transfusions prolong heart allograft survival but lymphocytes from the same donor are acutely rejected. Jaskłowska-Englisz M; Olszewski WL Transplant Proc; 1994 Dec; 26(6):3463. PubMed ID: 7998224 [No Abstract] [Full Text] [Related]
45. Enhancement of renal allografts by simultaneous cyclosporine and donor-specific blood transfusion. Francis DM; Masendycz PJ; Dumble LJ; Clunie GJ Transplant Proc; 1987 Feb; 19(1 Pt 2):1464-6. PubMed ID: 3274356 [No Abstract] [Full Text] [Related]
46. Evaluation of autolymphocytoxic antibody in the highly presensitized patient. Ettenger R; Robertson L Transplant Proc; 1987 Feb; 19(1 Pt 1):775-6. PubMed ID: 3274871 [No Abstract] [Full Text] [Related]
47. Synergistic effect of cholera toxin with cyclosporine and azathioprine on survival of rat renal allografts. Asano T; Murai M; Nakamura H Transplant Proc; 1993 Feb; 25(1 Pt 1):761-2. PubMed ID: 8438471 [TBL] [Abstract][Full Text] [Related]
48. Specific acceptance of cardiac allografts after treatment with antibodies to CD80 and CD86 in mice. Bashuda H; Seino K; Kano M; Sato K; Azuma M; Yagita H; Okumura K Transplant Proc; 1996 Apr; 28(2):1039-41. PubMed ID: 8623220 [No Abstract] [Full Text] [Related]
49. [The effect of pretransplantation blood transfusions on the survival of the kidney allograft]. Drannik GN; Driianskaia VE Urol Nefrol (Mosk); 1989; (4):70-4. PubMed ID: 2678680 [No Abstract] [Full Text] [Related]
51. Spleen mixed leukocyte chimerism and induction of tolerance in rat renal allograft recipients conditioned with donor-specific blood transfusions and cyclosporine. Llull R; Mañez R; Domenech N; Starzl TE; Black KS; Hewitt CW Transplant Proc; 1995 Aug; 27(4):2374-6. PubMed ID: 7652844 [No Abstract] [Full Text] [Related]
52. Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4(+)CD25(+) regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation. Pu LY; Wang XH; Zhang F; Li XC; Yao AH; Yu Y; Lv L; Li GQ Surgery; 2007 Jul; 142(1):67-73. PubMed ID: 17630002 [TBL] [Abstract][Full Text] [Related]
53. Local immunosuppressive therapy with monoclonal anti-T-cell antibody on renal allograft survival in the rat. II. Phenotypic and functional assessment of spleen cells. Yoshimura N; Lee CJ; Shiho O; Kita M; Imanishi J; Oka T Transplant Proc; 1995 Feb; 27(1):390-1. PubMed ID: 7879033 [No Abstract] [Full Text] [Related]
55. Eight-year actuarial graft and patient survival of kidney transplants in highly immunized recipients pretreated with total lymphoid irradiation: a single-center experience. Molajoni ER; Bachetoni A; Cinti P; Poli L; Caricato M; Pretagostini R; Vetere A; Berloco P; Alfani D; Cortesini R Transplant Proc; 1993 Feb; 25(1 Pt 1):776-7. PubMed ID: 8438477 [No Abstract] [Full Text] [Related]
56. Release of interleukins during tolerance and rejection of human renal allografts. Charpentier B; Lantz O; Lang P; Martin B; Fries D Transplant Proc; 1987 Feb; 19(1 Pt 2):1572-3. PubMed ID: 3274385 [No Abstract] [Full Text] [Related]
57. Immunosuppressive mechanisms of deoxymethylspergualin and FK 506 on in vitro cytotoxic T lymphocytes. Nakata S; Shirakura R; Ito T; Fukuzawa M; Miyagawa S; Yamamoto S; Nozaki T; Matsumiya G; Izutani H; Matsuda H Transplant Proc; 1994 Aug; 26(4):1930-2. PubMed ID: 7520613 [No Abstract] [Full Text] [Related]
58. Permissible mismatches, acceptable mismatches, and tolerance: new trends in decision making. van Rood JJ; Lagaaij EL; Doxiadis I; Roelen D; Persijn G; Claas F Clin Transpl; 1993; ():285-92. PubMed ID: 7918162 [TBL] [Abstract][Full Text] [Related]
59. The weaker the histoincompatibility, the greater the effectiveness of specific immunoblocking antibodies: a new immunogenetic rule of transplantation. Hildemann WH; Mullen Y Transplant Proc; 1973 Mar; 5(1):617-20. PubMed ID: 4572121 [No Abstract] [Full Text] [Related]
60. Differences in immunologic unresponsiveness after MHC-incompatible heart transplantation induced by donor-specific blood transfusion. Bektas H; Klempnauer J; Jörns A Transplant Proc; 1993 Oct; 25(5):2870-1. PubMed ID: 8212269 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]